deltatrials
Completed PHASE1 NCT00002711

Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

A PHASE I TRIAL OF COMBINED MODALITY THERAPY FOR LOCALIZED ESOPHAGEAL CANCER: CISPLATIN-PACLITAXEL FOLLOWED BY RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ESCALATING DOSES OF PACLITAXEL

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Esophageal Cancer
Interventions chemotherapy cisplatin low-LET electron therapy low-LET photon therapy paclitaxel
Updated 5 times since 2017 Last updated: Jul 1, 2013 Started: Oct 31, 1995 Primary completion: Oct 31, 2000 Completion: Oct 31, 2000

Listed as NCT00002711, this PHASE1 trial focuses on Esophageal Cancer and remains completed. Sponsored by Memorial Sloan Kettering Cancer Center, it has been updated 5 times since 1995, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Oct 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Memorial Sloan Kettering Cancer Center
  • National Cancer Institute (NCI)
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • New York, United States